WELCOME TO
KAIROS PHARMA
Cutting-edge therapeutics for cancer patients.
WELCOME TO
KAIROS PHARMA
Cutting-edge therapeutics for cancer patients.
About us
Kairos Pharma is a clinical-stage biopharmaceutical company focused on developing a diversified pipeline of cutting-edge oncology therapeutics that reverse the inhibitory effects of cancer on the immune system.
We are advancing our portfolio of innovative drug candidates designed to reverse resistance and immune suppression from cancer, led by the Clinical Chief of Neurosurgery and Director of the Brain Tumor Center at Cedars Sinai.
Advancing
Immunotherapy
Kairos Pharma is developing small molecules that target central “checkpoints” of the immune response to cancer. In addition, Kairos is developing an activated T cell therapy that transforms a patient’s T cells into killer activated T cells against the stem cells that drive the patient’s cancer.
New technologies to reverse key mechanisms of immune suppression and transform the way cancer is treated.
About us
Kairos Pharma is a clinical-stage biopharmaceutical company focused on developing a diversified pipeline of cutting-edge oncology therapeutics that reverse the inhibitory effects of cancer on the immune system.
We are advancing our portfolio of innovative drug candidates designed to reverse resistance and immune suppression from cancer, led by the Clinical Chief of Neurosurgery and Director of the Brain Tumor Center at Cedars Sinai.
Advancing Immunotherapy
Kairos Pharma is developing small molecules that target central “checkpoints” of the immune response to cancer. In addition, Kairos is developing an activated T cell therapy that transforms a patient’s T cells into killer activated T cells against the stem cells that drive the patient’s cancer.
New technologies to reverse key mechanisms of immune suppression and transform the way cancer is treated.
